BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29695767)

  • 21. Neurofibromatosis type 1 (NF1): diagnosis and management.
    Ferner RE; Gutmann DH
    Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating current basic research into future therapies for neurofibromatosis type 1.
    Brosseau JP; Liao CP; Le LQ
    Br J Cancer; 2020 Jul; 123(2):178-186. PubMed ID: 32439933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours.
    Prasad BCM; Chandra VVR; Sudarsan A; Kumar PS; Sarma PVGK
    J Clin Neurosci; 2018 Jul; 53():62-68. PubMed ID: 29680440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.
    Sohier P; Luscan A; Lloyd A; Ashelford K; Laurendeau I; Briand-Suleau A; Vidaud D; Ortonne N; Pasmant E; Upadhyaya M
    Genes Chromosomes Cancer; 2017 May; 56(5):421-426. PubMed ID: 28124441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
    Jiang C; McKay RM; Lee SY; Romo CG; Blakeley JO; Haniffa M; Serra E; Steensma MR; Largaespada D; Le LQ
    J Invest Dermatol; 2023 Aug; 143(8):1369-1377. PubMed ID: 37318402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
    Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
    Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological malignancies in neurofibromatosis type 1.
    Eoli M; Saletti V; Finocchiaro G
    Curr Opin Oncol; 2019 Nov; 31(6):554-561. PubMed ID: 31436563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
    Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
    Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
    Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
    Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
    Wimmer K
    Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
    Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
    Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal neurofibromatosis in a family with classical neurofibromatosis type 1 and a novel NF1 gene mutation.
    Nicita F; Torrente I; Spalice A; Bottillo I; Papetti L; Pinna V; Ursitti F; Ruggieri M
    J Clin Neurosci; 2014 Feb; 21(2):328-30. PubMed ID: 23954459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NF1 gene revisited - from bench to bedside.
    Yap YS; McPherson JR; Ong CK; Rozen SG; Teh BT; Lee AS; Callen DF
    Oncotarget; 2014 Aug; 5(15):5873-92. PubMed ID: 25026295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous neurofibromas: Current clinical and pathologic issues.
    Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
    Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
    Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
    Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
    Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
    Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
    Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
    Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Giraud JS; Bièche I; Pasmant É; Tlemsani C
    Expert Opin Investig Drugs; 2023; 32(10):941-957. PubMed ID: 37747491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis type 1.
    Cimino PJ; Gutmann DH
    Handb Clin Neurol; 2018; 148():799-811. PubMed ID: 29478615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.